CN105198790B - 促进双阴性t细胞体外增殖的四环化合物 - Google Patents
促进双阴性t细胞体外增殖的四环化合物 Download PDFInfo
- Publication number
- CN105198790B CN105198790B CN201510186837.4A CN201510186837A CN105198790B CN 105198790 B CN105198790 B CN 105198790B CN 201510186837 A CN201510186837 A CN 201510186837A CN 105198790 B CN105198790 B CN 105198790B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- compound
- car
- vitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510186837.4A CN105198790B (zh) | 2015-04-20 | 2015-04-20 | 促进双阴性t细胞体外增殖的四环化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510186837.4A CN105198790B (zh) | 2015-04-20 | 2015-04-20 | 促进双阴性t细胞体外增殖的四环化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105198790A CN105198790A (zh) | 2015-12-30 |
CN105198790B true CN105198790B (zh) | 2018-02-16 |
Family
ID=54946791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510186837.4A Active CN105198790B (zh) | 2015-04-20 | 2015-04-20 | 促进双阴性t细胞体外增殖的四环化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105198790B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109401969B (zh) * | 2018-12-13 | 2024-02-02 | 珠海西格膜生物技术有限公司 | 一种细胞工厂的管道连接***及其使用方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1882342A (zh) * | 2003-09-17 | 2006-12-20 | 艾科斯有限公司 | Chk1抑制剂在控制细胞增殖中的应用 |
CN102695413A (zh) * | 2009-11-10 | 2012-09-26 | 麦赛尔控股有限公司 | 稳定的脂肪酸的制剂 |
CN104136458A (zh) * | 2012-02-22 | 2014-11-05 | 宾夕法尼亚大学董事会 | 在第二代嵌合抗原受体中cd2信号传导结构域的使用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013049307A2 (en) * | 2011-09-30 | 2013-04-04 | University Of Miami | Enhanced immune memory development by aptamer targeted mtor inhibition of t cells |
AU2014248119B2 (en) * | 2013-04-03 | 2019-06-20 | Memorial Sloan-Kettering Cancer Center | Effective generation of tumor-targeted T-cells derived from pluripotent stem cells |
WO2015023551A1 (en) * | 2013-08-13 | 2015-02-19 | Bionumerik Pharmaceuticals, Inc. | Administration of karenitecin for the treatment of advanced ovarian cancer, including chemotherapy-resistant and/or the mucinous adenocarcinoma sub-types |
-
2015
- 2015-04-20 CN CN201510186837.4A patent/CN105198790B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1882342A (zh) * | 2003-09-17 | 2006-12-20 | 艾科斯有限公司 | Chk1抑制剂在控制细胞增殖中的应用 |
CN102695413A (zh) * | 2009-11-10 | 2012-09-26 | 麦赛尔控股有限公司 | 稳定的脂肪酸的制剂 |
CN104136458A (zh) * | 2012-02-22 | 2014-11-05 | 宾夕法尼亚大学董事会 | 在第二代嵌合抗原受体中cd2信号传导结构域的使用 |
Also Published As
Publication number | Publication date |
---|---|
CN105198790A (zh) | 2015-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade | |
Golán et al. | NK cell-based glioblastoma immunotherapy | |
Kobayashi et al. | γδ T cell immunotherapy—a review | |
US20210030794A1 (en) | Gamma delta t cells and uses thereof | |
Casey et al. | IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype | |
CN104789595A (zh) | 嵌合抗原受体双阴性t细胞的构建方法 | |
CN103756963B (zh) | 一种体外扩增nk细胞的方法 | |
Akbar et al. | Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles | |
Kim et al. | Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease | |
CN105238754B (zh) | 一种高增殖力和高杀伤力nk细胞的体外培养方法 | |
CN103232973A (zh) | 一种k562细胞扩增激活nk细胞的方法 | |
Kang et al. | The advances and challenges of NK cell-based cancer immunotherapy | |
Liu et al. | NK cell plasticity in cancer | |
Nakasone et al. | Therapeutic benefits targeting B-cells in chronic graft-versus-host disease | |
Fiorcari et al. | Nurse-like cells and chronic lymphocytic leukemia b cells: A mutualistic crosstalk inside tissue microenvironments | |
Fernández et al. | Optimizing the procedure to manufacture clinical-grade NK cells for adoptive immunotherapy | |
Poggio et al. | Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas | |
Kciuk et al. | Recent advances in molecular mechanisms of cancer immunotherapy | |
Oh et al. | Cryopreserved human natural killer cells exhibit potent antitumor efficacy against orthotopic pancreatic cancer through efficient tumor-homing and cytolytic ability | |
CN106222141A (zh) | Nk细胞培养液和细胞培养方法 | |
CN105198790B (zh) | 促进双阴性t细胞体外增殖的四环化合物 | |
CN104039333A (zh) | 移植物抗宿主疾病的治疗或预防方法 | |
WO2020185056A3 (ko) | 타가면역세포배양방법, 그 방법으로 얻어진 면역세포배양액 및 이를 포함하는 면역세포치료제 | |
CN110205293A (zh) | 一种加强型高效治疗肺癌的nk免疫细胞的制备方法及应用 | |
CN107708727A (zh) | 一种用于治疗肝癌的肿瘤疫苗及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190808 Address after: Room 411, Building 15, No. 8, Jinfeng Road, Suzhou High-tech Zone, Jiangsu Province Patentee after: Suzhou pharos Biological Medicine Technology Co.,Ltd. Address before: Room 802, Building 7, 300 Lane, Jinxiu Road, Pudong New Area, Shanghai 200000 Patentee before: Fan Guohuang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200628 Address after: Room 402, building 8, 760 xinjunhuan Road, Minhang District, Shanghai, 201100 Patentee after: Anmengde Pharmaceutical Technology (Shanghai) Co.,Ltd. Address before: Room 411, Building 15, No. 8, Jinfeng Road, Suzhou High-tech Zone, Jiangsu Province Patentee before: Suzhou pharos Biological Medicine Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 402, building 8, 760 Xinjun Ring Road, Minhang District, Shanghai 201100 Patentee after: Aimeifei Biopharmaceutical Technology (Shanghai) Co.,Ltd. Address before: Room 402, building 8, 760 Xinjun Ring Road, Minhang District, Shanghai 201100 Patentee before: Anmengde Pharmaceutical Technology (Shanghai) Co.,Ltd. |